Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-12

Clinical Trial Update: Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing non-invasive test-guided tailored therapy to empiric treatment for Helicobacter pylori infection, focusing on antibiotic resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Bari | Conditions: Helicobacter Pylori Infection, Antibiotic Resistant Infection | Phase 3 | Status: UNKNOWN